Incyte Corporation ( INCY) - Key Metrics
INCY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $7.63 | $1.52 | $2.75 | $2.64 |
| 2025Q3 | $6.98 | $2.17 | $2.86 | $2.78 |
| 2025Q2 | $6.27 | $2.09 | $0.23 | $0.13 |
| 2025Q1 | $5.44 | $0.82 | $1.37 | $1.36 |
INCY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 16.29 |
| 2025Q3 | ? | 9.78 |
| 2025Q2 | ? | 8.15 |
| 2025Q1 | ? | 18.54 |
INCY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.91% | ? |
| 2025Q4 | 2.67% | ? |
| 2025Q3 | 3.28% | ? |
| 2025Q2 | 0.19% | ? |
| 2025Q1 | 2.24% | ? |
INCY
Price: $97.98
52 week price:
Earnings Per Share: 7.10 USD
P/E Ratio: 13.68
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.0 million
Ebitda: -135.0 millionMarket Capitalization: 19.9 billion